PCN45 UK COST-EFFECTIVENESS ANALYSES OF DOCETAXEL VERSUS GENERIC PACLITAXEL ONCE WEEKLY AND NAB-PACLITAXEL IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER (MBC) PROGRESSED AFTERANTHRACYCLINE CHEMOTHERAPY
Abstract
Authors
A Benedict D Cameron H Corson S Jones